These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8438369)

  • 41. Tolerance to islet xenografts induced by dual manipulation of antigen presentation and co-stimulation.
    Markees TG; Appel MC; Noelle RJ; Mordes JP; Greiner DL; Rossini AA
    Transplant Proc; 1996 Apr; 28(2):814-5. PubMed ID: 8623413
    [No Abstract]   [Full Text] [Related]  

  • 42. Transplantation of microencapsulated islets in rats: evidence for induction of fibrotic overgrowth by islet alloantigens released from microcapsules.
    Horcher A; Zekorn T; Siebers U; Klöck G; Frank H; Houben R; Bretzel RG; Zimmermann U; Federlin K
    Transplant Proc; 1994 Apr; 26(2):784-6. PubMed ID: 8171661
    [No Abstract]   [Full Text] [Related]  

  • 43. Xenoislet rejection following pig-to-rat, pig-to-primate, and pig-to-man transplantation.
    Groth CG; Korsgren O; Wennberg L; Tibell A; Zhu S; Sundberg B; Söderlund J; Biberfeld P; Satake M; Möller E; Wallgren AC; Karlsson-Parra A
    Transplant Proc; 1996 Apr; 28(2):538-9. PubMed ID: 8623254
    [No Abstract]   [Full Text] [Related]  

  • 44. Microlymphocytotoxicity assay to assess reactivity of rodent sera to large animal T lymphocytes.
    Betz JK; Ketchum RJ; Levy MM; Park DH; Perloff JR; Grodberg JB; Kearns J; Zmijewski CM; Brayman KL
    Transplant Proc; 1994 Dec; 26(6):3449-50. PubMed ID: 7998216
    [No Abstract]   [Full Text] [Related]  

  • 45. Participation of donor adhesion molecules in islet xenograft rejection.
    Ohta Y; Gotoh M; Fukuzaki T; Nishihara M; Yagita H; Okumura K; Miyasaka M; Monden M
    Transplant Proc; 1995 Feb; 27(1):256-7. PubMed ID: 7878992
    [No Abstract]   [Full Text] [Related]  

  • 46. Concordant xenoreactive and alloreactive cell-mediated immune responses are relatively comparable.
    Rehman A; Tu Y; Walp L; Flye MW
    Transplant Proc; 1996 Apr; 28(2):658-9. PubMed ID: 8623330
    [No Abstract]   [Full Text] [Related]  

  • 47. Cell-mediated cytotoxicity of peripheral lymphocytes as a new approach to early diagnosis of ongoing allograft rejection.
    Kuttler B; Wanka H; Hahn HJ
    Transplant Proc; 1994 Apr; 26(2):730-1. PubMed ID: 8171629
    [No Abstract]   [Full Text] [Related]  

  • 48. Experimental and clinical experience with xenoislet transplantation.
    Groth CG; Tibell A; Wennberg L; Korsgren O
    Transplant Proc; 1996 Dec; 28(6):3515. PubMed ID: 8962366
    [No Abstract]   [Full Text] [Related]  

  • 49. Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1.
    Coulombe M; Yang H; Guerder S; Flavell RA; Lafferty KJ; Gill RG
    J Immunol; 1996 Dec; 157(11):4790-5. PubMed ID: 8943380
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of cholera toxin on pancreatic islet transplantation in mice.
    Takeda Y; Satomi S; Miura S; Koja S; Morimoto K; Okamoto M; Oguma S; Taguchi Y; Mori S
    Transplant Proc; 1991 Feb; 23(1 Pt 1):873-4. PubMed ID: 1990709
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immuno-isolation of xenogenic islands of Langerhans in a tissue engineered autologous cartilage capsule].
    Pollok JM; Ibarra C; Broelsch CE; Vacanti JP
    Zentralbl Chir; 1998; 123(7):830-3. PubMed ID: 9746983
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymphocyte infiltration following allo- and xenomyoblast transplantation in mice.
    Guérette B; Asselin I; Vilquin JT; Roy R; Tremblay JP
    Transplant Proc; 1994 Dec; 26(6):3461-2. PubMed ID: 7998223
    [No Abstract]   [Full Text] [Related]  

  • 53. Humoral and cellular recognition of discordant xenogeneic Langerhans islets.
    Inverardi L; Pardi R
    Transplant Proc; 1994 Apr; 26(2):1034-6. PubMed ID: 8171459
    [No Abstract]   [Full Text] [Related]  

  • 54. Xenogeneic but not allogeneic pancreatic islet graft survival in recipients lacking humoral immunity and major histocompatibility complex class II antigens.
    Chu G; Markmann JF; Ahn M; Chang E; DeMatteo RP; Ketchum RJ; Brayman KI; Deng S; Barker CF
    Transplant Proc; 1997; 29(1-2):901-2. PubMed ID: 9123579
    [No Abstract]   [Full Text] [Related]  

  • 55. Vulnerability of allogeneic and xenogeneic pancreatic islets to alloantisera.
    Frangipane LG; Poole TW; Barker CF; Silvers WK
    Transplant Proc; 1977 Mar; 9(1):371-3. PubMed ID: 141129
    [No Abstract]   [Full Text] [Related]  

  • 56. Lack of cross-species sensitization between skin allo- and xenotransplants in mice.
    Vizler C; Jánossy T; Tabi Z; Végh P
    Transplant Proc; 1994 Jun; 26(3):1324-5. PubMed ID: 8029925
    [No Abstract]   [Full Text] [Related]  

  • 57. Manipulation of pancreatic islet cells in allotransplantation.
    Tze WJ; Tai J
    Transplant Proc; 1982 Dec; 14(4):714-23. PubMed ID: 6820204
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on the two-signal model for T cell activation in vivo.
    Babcock SK; Gill RG; Bellgrau D; Lafferty KJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):303-6. PubMed ID: 3103279
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of lymphokine-induced MHC antigen expression on islet allograft survival.
    Markmann JF; Bassiri HF; Barker CF; Naji A
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2723-4. PubMed ID: 2495681
    [No Abstract]   [Full Text] [Related]  

  • 60. Morphologic evaluation of xenotransplanted neonatal islets of Langerhans and fetal pancreata from rats to nude mice.
    Yderstraede KB; Starklint H; Thye-Rønn P
    Transplant Proc; 1994 Jun; 26(3):1106-7. PubMed ID: 7518106
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.